[Proteolytic enzymes and the inhibition of their activity in multiple sclerosis].
D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D002403:Cathepsins / Q000037:antagonists & inhibitors* / Q000502:physiology; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology; D009186:Myelin Sheath / Q000473:pathology; D009410:Nerve Degeneration / Q000187:drug effects
D000614:Aminocaproates; D002403:Cathepsins; D015119:Aminocaproic Acid
Enzymy proteolityczne i hamowanie ich aktywności w stwardnieniu rozsianym.